Invex Therapeutics Balance Sheet Health

Financial Health criteria checks 6/6

Invex Therapeutics has a total shareholder equity of A$5.7M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$6.1M and A$431.6K respectively.

Key information

0%

Debt to equity ratio

AU$0

Debt

Interest coverage ration/a
CashAU$6.03m
EquityAU$5.69m
Total liabilitiesAU$431.63k
Total assetsAU$6.12m

Recent financial health updates

Recent updates

We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Jun 09
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Jan 11
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

We Think Invex Therapeutics (ASX:IXC) Can Afford To Drive Business Growth

Aug 24
We Think Invex Therapeutics (ASX:IXC) Can Afford To Drive Business Growth

Companies Like Invex Therapeutics (ASX:IXC) Are In A Position To Invest In Growth

May 10
Companies Like Invex Therapeutics (ASX:IXC) Are In A Position To Invest In Growth

Companies Like Invex Therapeutics (ASX:IXC) Can Afford To Invest In Growth

Jan 25
Companies Like Invex Therapeutics (ASX:IXC) Can Afford To Invest In Growth

We're Interested To See How Invex Therapeutics (ASX:IXC) Uses Its Cash Hoard To Grow

Sep 27
We're Interested To See How Invex Therapeutics (ASX:IXC) Uses Its Cash Hoard To Grow

We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Mar 31
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Should You Review Recent Insider Transactions At Invex Therapeutics Ltd (ASX:IXC)?

Feb 06
Should You Review Recent Insider Transactions At Invex Therapeutics Ltd (ASX:IXC)?

We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Dec 15
We're Hopeful That Invex Therapeutics (ASX:IXC) Will Use Its Cash Wisely

Financial Position Analysis

Short Term Liabilities: IXC's short term assets (A$6.1M) exceed its short term liabilities (A$431.6K).

Long Term Liabilities: IXC has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: IXC is debt free.

Reducing Debt: IXC has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IXC has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: IXC has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 29.9% each year.


Discover healthy companies